Globus Medical Valuation
Is GMED * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of GMED * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: GMED * (MX$990) is trading below our estimate of fair value (MX$4143.63)
Significantly Below Fair Value: GMED * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for GMED *?
Other financial metrics that can be useful for relative valuation.
What is GMED *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$8.90b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 4.7x |
Enterprise Value/EBITDA | 18.6x |
PEG Ratio | 3.3x |
Price to Earnings Ratio vs Peers
How does GMED *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 57.3x | ||
PEN Penumbra | 77.9x | 26.2% | US$7.3b |
MASI Masimo | 91.1x | 34.0% | US$7.1b |
AFX Carl Zeiss Meditec | 28.9x | 12.7% | €7.5b |
6869 Sysmex | 31.4x | 13.2% | JP¥1.6t |
GMED * Globus Medical | 133x | 40.9% | Mex$8.9b |
Price-To-Earnings vs Peers: GMED * is expensive based on its Price-To-Earnings Ratio (133x) compared to the peer average (57.3x).
Price to Earnings Ratio vs Industry
How does GMED *'s PE Ratio compare vs other companies in the Global Medical Equipment Industry?
Price-To-Earnings vs Industry: GMED * is expensive based on its Price-To-Earnings Ratio (133x) compared to the Global Medical Equipment industry average (27.1x).
Price to Earnings Ratio vs Fair Ratio
What is GMED *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 133x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate GMED *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.